Albemarle Co. (ALB) Shares Sold by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. cut its stake in Albemarle Co. (NYSE:ALB) by 5.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 50,131 shares of the specialty chemicals company’s stock after selling 2,712 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in Albemarle were worth $3,863,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Benjamin F. Edwards & Company Inc. lifted its holdings in Albemarle by 7.7% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 1,998 shares of the specialty chemicals company’s stock worth $154,000 after buying an additional 143 shares during the period. AdvisorNet Financial Inc lifted its holdings in shares of Albemarle by 5.1% during the fourth quarter. AdvisorNet Financial Inc now owns 4,106 shares of the specialty chemicals company’s stock valued at $316,000 after purchasing an additional 198 shares during the last quarter. Proficio Capital Partners LLC lifted its holdings in shares of Albemarle by 143.1% during the fourth quarter. Proficio Capital Partners LLC now owns 350 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 206 shares during the last quarter. B & T Capital Management DBA Alpha Capital Management lifted its holdings in shares of Albemarle by 1.4% during the fourth quarter. B & T Capital Management DBA Alpha Capital Management now owns 16,534 shares of the specialty chemicals company’s stock valued at $1,274,000 after purchasing an additional 225 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its holdings in shares of Albemarle by 2.1% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 11,123 shares of the specialty chemicals company’s stock valued at $858,000 after purchasing an additional 226 shares during the last quarter. Institutional investors and hedge funds own 93.13% of the company’s stock.

Shares of ALB opened at $84.73 on Friday. The company has a market cap of $9.07 billion, a P/E ratio of 15.46, a PEG ratio of 0.91 and a beta of 1.66. The company has a quick ratio of 1.10, a current ratio of 1.69 and a debt-to-equity ratio of 0.37. Albemarle Co. has a twelve month low of $71.89 and a twelve month high of $108.74.

Albemarle (NYSE:ALB) last announced its quarterly earnings results on Wednesday, February 20th. The specialty chemicals company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.46 by $0.07. The company had revenue of $921.70 million during the quarter, compared to the consensus estimate of $894.45 million. Albemarle had a net margin of 20.55% and a return on equity of 15.82%. The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.34 earnings per share. On average, sell-side analysts anticipate that Albemarle Co. will post 6.23 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, April 1st. Investors of record on Friday, March 15th will be given a dividend of $0.3675 per share. The ex-dividend date is Thursday, March 14th. This represents a $1.47 annualized dividend and a dividend yield of 1.73%. This is an increase from Albemarle’s previous quarterly dividend of $0.34. Albemarle’s dividend payout ratio (DPR) is 24.45%.

In other Albemarle news, EVP Karen G. Narwold sold 1,243 shares of Albemarle stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $91.00, for a total value of $113,113.00. Following the completion of the sale, the executive vice president now owns 34,757 shares of the company’s stock, valued at approximately $3,162,887. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Karen G. Narwold sold 1,295 shares of Albemarle stock in a transaction that occurred on Friday, January 4th. The stock was sold at an average price of $74.76, for a total transaction of $96,814.20. Following the completion of the sale, the executive vice president now directly owns 31,028 shares of the company’s stock, valued at approximately $2,319,653.28. The disclosure for this sale can be found here. Insiders have sold 8,842 shares of company stock valued at $728,599 in the last three months. 0.80% of the stock is owned by insiders.

Several equities analysts have recently issued reports on the stock. Deutsche Bank lifted their target price on shares of Albemarle from $84.00 to $95.00 and gave the company a “hold” rating in a report on Monday, February 25th. ValuEngine upgraded shares of Albemarle from a “strong sell” rating to a “sell” rating in a report on Friday, February 22nd. Loop Capital lifted their target price on shares of Albemarle from $112.00 to $119.00 and gave the company a “buy” rating in a report on Thursday, February 21st. reiterated a “buy” rating and set a $157.00 target price on shares of Albemarle in a report on Thursday, February 14th. Finally, Citigroup lowered shares of Albemarle from a “buy” rating to a “neutral” rating and lowered their target price for the company from $90.00 to $81.00 in a report on Tuesday, February 5th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the stock. Albemarle has an average rating of “Hold” and a consensus price target of $104.68.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another site, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.com-unik.info/2019/03/15/albemarle-co-alb-shares-sold-by-edmond-de-rothschild-holding-s-a.html.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium and Advanced Materials segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and automobiles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets.

See Also: Ex-Dividend

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit